semaglutide cardiovascular outcomes news 2025 october New Science Suggests Improves CV Beyond Weight Loss Semaglutide and cardiovascular outcomes by

Learn if tanning beds help with depression

He also confirmed that more products are in the pipeline, including an oral semaglutide pill aimed at weight loss.

Three large observational studies provide more data

US pharma giant Pfizer presented detailed results from multiple Phase IIb studies of berobenatide (PF-3944), an investigational, potential first-in-class monthly GLP-1 receptor agonist (GLP-1 RA) peptide, during a late-breaking expert symposium at the 86th Scientific Sessions of the American Diabetes Association (ADA).

Discover if doing fasted cardio while on GLP-1 weight loss injections boosts fat burning and accelerates your results

It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels